|

Antigen-specific T cells CART/CTL and DCvac Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

  • Shenzhen Geno-Immune Medical Institute2

Indications

  • Cancer2
  • B-cell Acute Lymphoblastic Leukemia1

Other2 trials

Immunotherapy Based on Antigen-specific Immune Effector Cells Targeting Neurofibromatosis or Schwannomatosis
Phase 1/2
NGS-MRD Assessment of Combination Immunotherapies Targeting B-ALL
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.